Literature DB >> 19675589

Multitargeted tyrosine kinase inhibitor stimulates expression of IL-6 and activates JAK2/STAT5 signaling in acute myelogenous leukemia cells.

C Nishioka, T Ikezoe, J Yang, A Yokoyama.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19675589     DOI: 10.1038/leu.2009.163

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  4 in total

1.  Development of novel adenosine monophosphate-activated protein kinase activators.

Authors:  Jih-Hwa Guh; Wei-Ling Chang; Jian Yang; Su-Lin Lee; Shuo Wei; Dasheng Wang; Samuel K Kulp; Ching-Shih Chen
Journal:  J Med Chem       Date:  2010-03-25       Impact factor: 7.446

2.  Interleukin-6: a potential biomarker of resistance to multitargeted receptor tyrosine kinase inhibitors in castration-resistant prostate cancer.

Authors:  Alexander Kutikov; Peter Makhov; Konstantin Golovine; Daniel J Canter; Mohit Sirohi; Ryan Street; Jay Simhan; Robert G Uzzo; Vladimir M Kolenko
Journal:  Urology       Date:  2011-10       Impact factor: 2.649

3.  A novel anti-c-Kit antibody-drug conjugate to treat wild-type and activating-mutant c-Kit-positive tumors.

Authors:  Jin-Ock Kim; Kwang-Hyeok Kim; Eun Ji Baek; Bomi Park; Min Kyung So; Byoung Joon Ko; Han-Jik Ko; Sang Gyu Park
Journal:  Mol Oncol       Date:  2021-08-29       Impact factor: 6.603

4.  Biological and therapeutic implications of a unique subtype of NPM1 mutated AML.

Authors:  Arvind Singh Mer; Emily M Heath; Seyed Ali Madani Tonekaboni; Nergiz Dogan-Artun; Sisira Kadambat Nair; Alex Murison; Laura Garcia-Prat; Liran Shlush; Rose Hurren; Veronique Voisin; Gary D Bader; Corey Nislow; Mattias Rantalainen; Soren Lehmann; Mark Gower; Cynthia J Guidos; Mathieu Lupien; John E Dick; Mark D Minden; Aaron D Schimmer; Benjamin Haibe-Kains
Journal:  Nat Commun       Date:  2021-02-16       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.